Prevention of 1-methyl-4-phenylpyridinium- and 6-hydroxydopamine-induced nitration of tyrosine hydroxylase and neurotoxicity by EUK-134, a superoxide dismutase and catalase mimetic, in cultured dopaminergic neurons
Oxidative stress has been implicated in the selective degeneration of dopaminergic (DAergic) neurons in Parkinson’s disease (PD). In this study, we tested the efficacy of EUK-134, a superoxide dismutase (SOD) and catalase mimetic, on the nitration of tyrosine hydroxylase (TH), a marker of oxidative...
Gespeichert in:
Veröffentlicht in: | Brain research 2000-10, Vol.881 (2), p.182-189 |
---|---|
Hauptverfasser: | , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Oxidative stress has been implicated in the selective degeneration of dopaminergic (DAergic) neurons in Parkinson’s disease (PD). In this study, we tested the efficacy of EUK-134, a superoxide dismutase (SOD) and catalase mimetic, on the nitration of tyrosine hydroxylase (TH), a marker of oxidative stress, and neurotoxicity produced by 1-methyl-4-phenylpyridinium (MPP
+) and 6-hydroxydopamine (6-OHDA) in primary DAergic neuron cultures. Exposure of cultures to 10 μM MPP
+ reduced dopamine (DA) uptake and the number of tyrosine hydroxylase immunoreactive (THir) neurons to 56 and 52% of control, while exposure to 30 μM 6-OHDA reduced DA uptake and the number of THir neurons to 58 and 59% of control, respectively. Pretreatment of cultures with 0.5 μM EUK-134 completely protected DAergic neurons against MPP
+- and 6-OHDA-induced neurotoxicity. Exposure of primary neuron cultures to either MPP
+ or 6-OHDA produced nitration of tyrosine residues in TH. Pretreatment of cultures with 0.5 μM EUK-134 completely prevented MPP
+- or 6-OHDA-induced nitration of tyrosine residues in TH. Taken together, these results support the idea that reactive oxygen species (ROS) are critically involved in MPP
+- and 6-OHDA-induced neurotoxicity and suggest a potential therapeutic role for synthetic catalytic scavengers of ROS, such as EUK-134, in the treatment of PD. |
---|---|
ISSN: | 0006-8993 1872-6240 |
DOI: | 10.1016/S0006-8993(00)02841-9 |